Effects of the Moderate CYP3A4 Inhibitor Erythromycin on the Pharmacokinetics of Palbociclib: A Randomized Crossover Trial in Patients With Breast Cancer
Research output: Contribution to journal › Article › peer-review
12Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Effects of the Moderate CYP3A4 Inhibitor Erythromycin on the Pharmacokinetics of Palbociclib: A Randomized Crossover Trial in Patients With Breast Cancer'. Together they form a unique fingerprint.